Skip to main content
Home logo

User account menu

Log inSearch

Main navigation

  • Home
  • Data Sources
  • Studies
  • Institutions
  • Networks
  • What's new
  • Support
  1. Home

Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (Covid-Vaccine-Monitor CVM)

23/08/2021
13/12/2024
EU PAS number:
EUPAS42504
Study
Finalised
Subscribe
Download as PDF

Secondary tabs

Administrative detailsMethodological aspectsData managementResources

Page content

  • Documents
  • Publications
  • ENCePP Seal
Documents
Study protocol
Initial protocol

CVM_WP1_Protocol_v2.0_20210714_final

English (793.44 KB - PDF)View document
Updated protocol

CVM_WP1_Protocol_v2.1_20210729

First published: 22/02/2024
English (1.42 MB - PDF)View document
Study results
Study results

EUPAS42504-105818

English (567.7 KB - PDF)View document
Study report
Other information
Publications
Study publications
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, O…
Luxi, N, Raethke, M, Ruijs, L, Schmikli, S, Riefolo, F, Trifiro, G, & Sturkenbo…
Luxi Nicoletta, Riefolo Fabio, Raethke Monika, van Hunsel Florence, Sturkenboom…
Francesco Ciccimarra et al. (2024). Safety Monitoring of COVID-19 Vaccines in P…
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results …
Safety of COVID-19 Vaccines among People with History of Allergy: A European Ac…
ENCePP Seal
ENCePP Seal documents

Share this page

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Privacy policy
Cookies
Legal notice

Contact

Contact us